Virginia · Nonprofit
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES (Virginia) receives grants from 8 organizations whose IRS filings report $356,966 to it, the largest being LALIT AND ANUBHA GUPTA FOUNDATION INC ($140,000). 5 of them have funded it in more than one year.
- Revenue FY2025
- $18M
- Funders on record
- 8
- Grants received
- $357k
- Net assets
- $28M
What American Association for the Study of Liver Diseases does
Mission
To advance and disseminate the science and practice of hepatology, and to promote liver health and quality patient care.
As stated on its FY2025 Form 990.
Programs
Meetings and education, including the liver meeting: aasld's dynamic educational programs provide healthcare professionals cutting-edge advancements in science and innovative new techniques to advance hepatology training and professional development through immersive face-to-face events and robust online learning platforms. These initiatives foster the exchange of groundbreaking research, elevate patient care, and spark new discoveries in liver disease management. The liver meeting, aasld's premier annual event, is a global cornerstone for the field of hepatology, showcasing transformative research and treatment outcomes. Attendees engage in plenary and parallel sessions, poster presentations, state-of-the-art lectures, meet-the-expert sessions, specialty courses, and special interest group programming fostering collaboration and knowledge-sharing among leading experts and practitioners. Additionally, aasld hosts focused stand-alone events like the emerging topic conferences, co-sponsors digestive disease week, and partners with domestic and international medical societies, government entities, and nonprofit organizations to deliver impactful educational programming in…
$9,743,304 spentof which $4,500 as grants$8,794,501 earned by the program55% of program spendingPublications: aasld's journals, hepatology, liver transplantation, and hepatology communications deliver peer-reviewed, high-impact research on liver and biliary tract diseases, setting the standard for scientific excellence in the field. Aasld's flagship journal, hepatology, publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished editorial board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Liver transplantation publishes cutting edge scientific breaktrliver transplantation, a specialized journal, provides authoritative insights into the latest advancements in liver transplantation. Hepatology communications, an open-access, peer-reviewed journal, ensures rapid dissemination of high-quality basic, translational, and clinical research, amplifying aasld's commitment to advancing hepatology worldwide.professional relations: aasld's professional relations initiatives strengthen the hepatology community through:1. Aasld practice…
$5,929,583 spentof which $1,208,397 as grants$1,279,000 earned by the program33% of program spendingMembership & mentorship: aasld's vibrant membership of over 7,000 professionalsspanning physicians, scientists, hepatologists, surgeons, pathologists, students, and allied health expertsdrives hepatobiliary research and patient care worldwide. The aasld mentorship program inspires and nurtures the next generation of hepatologists by pairing medical, surgical, and pediatric residents, fellows, and early-career professionals with seasoned mentors. This program ensures a legacy of skilled, knowledgeable hepatologists dedicated to academic medicine and patient care.website: aasld's websites (www.aasld.org and hcvguidelines.org) serve as a vital hub for members, scientists, physicians, allied health professionals, and the public, offering seamless access to cutting-edge hepatology resources. With over 2.1 million annual visitors, the site facilitates exploration of research, educational offerings, and professional opportunities in hepatology.communicationsaasld keeps its community informed through the biweekly aasld e-news, delivering updates on research, milestones, and policy developments to members. The association also amplifies its impact through strategic media relations,…
$2,141,064 spentof which $110,000 as grants$1,916,505 earned by the program12% of program spending
The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $17,813,951.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $42M to $35M (−17%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2021 6%. Grants only. Government contracts and fees sit inside program revenue.
19% of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES’s revenue is contributions — more donation-reliant than the typical peer (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 8 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2018 → 2023: the base broadened from 1 funder to 4 funders, grant income rose $20k → $76k.
3 of 8 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 11% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES leans on a few funders — its largest provides 39% of grant income and the top three 80%; half comes from just 2 funders.
the vertical line marks half of all grant income — 2 funders to its left
35% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES.
Largest funder’s share by year: 2018 100% · 2019 99% · 2020 78% · 2021 61% · 2022 73% · 2023 72% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
60% of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES's funders are still giving 3 years after their first grant; 63% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES draws 100% of its grant income from funders outside Virginia, across 5 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $40k arriving through sponsors registered in 3 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES is better cushioned than half of the 2,969 health nonprofits its size.
this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025
Organizations like AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Virginia
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
88% of spending goes to programs.
Governance
Public support
79%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 24 states
Part of a family of 1 related entity
- Aasld Foundation · exempt
Screen this organization
A dated, signed PDF of the compliance screen for AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES?
- AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES (Virginia) receives grants from 8 organizations whose IRS filings report $356,966 to it, the largest being LALIT AND ANUBHA GUPTA FOUNDATION INC ($140,000). 5 of them have funded it in more than one year.
- How many funders does AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES have?
- IRS filings report 8 organizations giving $356,966 in grants to AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES, 5 of which have funded it in more than one year.
- Who is the largest funder of AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES?
- LALIT AND ANUBHA GUPTA FOUNDATION INC is the largest funder on record, with $140,000 in grants. The full list of funders is on this page.
- How can an organization like AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Virginia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 8 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing